Properties |
Information |
PhytoCAT-ID |
PhytoCAT-584 |
Phytochemical name or plant extracts |
Amooranin |
PMID |
14503804 |
Literature evidence |
Novel drug amooranin induces apoptosis through caspase activity in human breast carcinoma cell lines. |
IUPAC name |
(4aS,6aS,6aS,6bR,8aR,12aS,14bS)-12a-(hydroxymethyl)-2,2,6a,6b,9,9-hexamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid |
Phytochemicals’ class or type of plant extracts |
Triterpenoid |
Source of phytochemicals or plant Extracts |
Amoora rohituka |
|
Geographical availability |
Andaman Is., Assam, Bangladesh, Bismarck Archipelago, Borneo, Cambodia, China South-Central, China Southeast, East Himalaya, Hainan, India, Jawa, Laos, Lesser Sunda Is., Malaya, Maluku, Myanmar, New Guinea, Nicobar Is., Philippines, Solomon Is., Sri Lanka, Sulawesi, Sumatera, Taiwan, Thailand, Vietnam |
Plant parts |
Stem |
Other cancers |
Breast cancer |
Target gene or protein |
Caspase 8 |
Gene or Protein evidence |
Flow cytometric analysis showed that AMR induced caspase-8 activation in 40.8-71% MCF-7, 28.5-43.2% MCF-7/TH and 4-32.8% MCF-10A cells at 1-8 microg/ml concentrations. |
Target pathways |
NA |
IC50 |
3.8 μg/mL against MCF-7
6.8 μg/mL against MCF-7/TH
6.9 μg/mL against MCF-10A |
Potency |
In situ cell death detection assay indicated that AMR caused 37.3-72.1% apoptotic cells in MCF-7, 32-48.7% in MCF-7/TH and 0-37.1% in MCF- 10A cells at 1-8 microg/ml concentrations. |
Cell line/ mice model |
MCF-7, MCF-7/TH, MCF-10A |
Additional information |
Our results suggest that AMR is a novel drug having potential for clinical development against human malignancies |
PubChem ID |
11503749 |
Additional PMIDs |
23475563 14503804 17028990 11933149 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:577579-1 |
Safety |
NA |